Table 3.
Frequency of distributions of symptoms between ANRE and Non-ANRE.
| Clinical characteristics | All(n = 176) | Non-ANRE(n = 36) | ANRE(n = 140) | p value |
|---|---|---|---|---|
| Seizures | 114(64.77) | 30(83.33) | 84(60.00) | 0.009 |
| Memory dysfunction | 131(74.43) | 22(61.11) | 109(77.86) | 0.04 |
| Psychosis | 158(89.77) | 27(75.00) | 131(93.57) | 0.003 |
| Decreased level of consciousness | 110(62.50) | 21(58.33) | 89(63.57) | 0.563 |
| Language problem | 118(67.05) | 22(61.11) | 96(68.57) | 0.396 |
| Dyskinesia | 39(22.16) | 7(19.44) | 32(22.86) | 0.660 |
| Gait instability and ataxia | 22(12.50) | 8(22.22) | 14(10.00) | 0.090 |
| Brainstem dysfunction | 68(38.64) | 16(44.44) | 52(37.14) | 0.422 |
| Muscle weakness | 46(26.14) | 14(38.89) | 32(22.86) | 0.051 |
ANRE:anti-NMDAR encephalitis